Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Japan
/
Pharmaceuticals & Biotech
/
Otsuka Holdings
4578
Otsuka Holdings
Global Healthcare Cost Controls Will Crush Profitability
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
08 Jun 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
JP¥7,200.00
11.3% overvalued
intrinsic discount
20 Aug
JP¥8,010.00
Loading
1Y
-5.0%
7D
1.1%
Author's Valuation
JP¥7.2k
11.3% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
JP¥7.2k
11.3% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
2t
2014
2017
2020
2023
2025
2026
2028
Revenue JP¥2.2t
Earnings JP¥184.5b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
1.94%
Pharma revenue growth rate
0.58%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
4.72%
Calculation
JP¥184.52b
Earnings '28
x
22.05x
PE Ratio '28
=
JP¥4.07t
Market Cap '28
JP¥4.07t
Market Cap '28
/
492.90m
No. shares '28
=
JP¥8.25k
Share Price '28
JP¥8.25k
Share Price '28
Discounted to 2025 @ 4.72% p.a.
=
JP¥7.19k
Fair Value '25